Urticaria after breakthrough Omicron BA.5.1 severe acute respiratory syndrome coronavirus 2 infection in a triple-vaccinated (Pfizer) patient: a case reportarticle Published on 2023-05-042024-09-05 Journal: Journal of Medical Case Reports [Category] update2024, [키워드] Case report postvaccination Rash SARS-CoV-2 skin urticaria [DOI] 10.1186/s13256-023-03904-2 PMC 바로가기 [Article Type] article
A comprehensive narrative review of the cutaneous manifestations associated with COVID-19Review Published on 2023-03-012023-07-10 Journal: International wound journal [Category] COVID19(2023년), [키워드] chilblain-like COVID-19 Cutaneous manifestations livedo reticularis maculopapular rash petechiae SARS-CoV-2 urticaria vesicular lesions. [DOI] 10.1111/iwj.13933 PMC 바로가기 [Article Type] Review
COVID-19 and cutaneous manifestations: A review of the published literatureReview Published on 2023-01-012024-09-02 Journal: Journal of cosmetic dermatology [Category] 대상포진, [키워드] COVID-19 Dermatology lesion or rash skin manifestation urticaria [DOI] 10.1111/jocd.15477 PMC 바로가기 [Article Type] Review
Case series of chronic spontaneous urticaria following COVID-19 vaccines: an unusual skin manifestationArticle Published on 2022-12-012023-07-10 Journal: European Journal of Clinical Pharmacology [Category] COVID19(2023년), [키워드] chronic COVID-19 vaccines SARS-CoV-2 Side effects urticaria [DOI] 10.1007/s00228-022-03399-8 PMC 바로가기
Diagnosis of stress-associated dermatologic conditions in New York City safety-net hospitals during the COVID-19 pandemicComment Published on 2022-11-012024-09-02 Journal: Journal of the American Academy of Dermatology [Category] 대상포진, [키워드] Acne coronavirus COVID-19 eczema psoriasis Stress telogen effluvium urticaria Zoster [DOI] 10.1016/j.jaad.2022.05.066 PMC 바로가기 [Article Type] Comment
Urticaria relapse after mRNA COVID-19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single-center experienceArticle Published on 2022-11-012022-11-15 Journal: Dermatologic therapy [Category] 진단, [키워드] acute urticaria adverse event affected analyzed appear characterized chronic chronic spontaneous urticaria Clinical characteristics Coronavirus disease 2019 COVID-19 COVID-19 vaccine described develop disease Frequency IgE less mechanism mRNA mRNA COVID-19 vaccine mRNA vaccines occur pandemic Patient patients treated Retrospective study single-center treated urticaria vaccination Vaccine wheals. [DOI] 10.1111/dth.15838 PMC 바로가기
Paucity of cutaneous manifestations of COVID-19 among inpatients at a referral hospital in IndiaResearch article Published on 2022-09-012022-10-05 Journal: JAAD International [Category] 진단, [키워드] 48 hour Admission causes Coagulopathy Comorbidity conducted COVID toes COVID-19 cross-sectional cross-sectional analysis Cutaneous cutaneous manifestation described diagnosed digital ischemia drug DVT hospital ICU patient ICUs India Inpatient intensive care unit moderate morbilliform rash mottling objective Patient patients with moderate peer review Prognosis Result RT-PCR severe COVID-19 severe disease skin systemic urticaria with COVID-19 [DOI] 10.1016/j.jdin.2022.01.001 [Article Type] Research article
Cutaneous reactions to COVID-19 vaccines: A reviewOriginal Article Published on 2022-02-172024-09-04 Journal: JAAD International [Category] 대상포진, [키워드] anaphylaxis Angioedema chilblains COVID-19 cutaneous reaction herpes zoster Immunity injection site reaction pityriasis rosea SCAR, severe cutaneous adverse reactions urticaria vaccination [DOI] 10.1016/j.jdin.2022.01.011 PMC 바로가기 [Article Type] Original Article
Advances and highlights in biomarkers of allergic diseases알레르기 질환 바이오마커의 발전과 하이라이트Review Published on 2021-12-012022-09-11 Journal: Allergy [Category] SARS, 바이오마커, [키워드] addition advance allergen allergen immunotherapy allergic allergic disease allergic diseases allergic rhinitis anaphylaxis approach Asthma asthmatic asthmatic patient Asthmatic patients atopic dermatitis Biomarker Biomarkers body fluid body fluids change characterized chronic urticaria clinically Clusters collected COVID-19 COVID-19 pandemic Data analysis diagnoses Diagnosis diagnosis and monitoring eosinophils epithelial food allergies fraction help highlight hypersensitivity immune response Immunotherapy include information Innate lymphoid cells lymphoid cells M2 macrophages macrophages management Mast cells mediators microbiota miRNAs nitric oxide noninvasive omics technologies outbreak parameter Perspective plethora point-of-care Precision precision medicine presenting pro-inflammatory mediators quantified recommendation Research robust serum sputum Th2 cells the disease therapeutic targets Treatment urticaria [DOI] 10.1111/all.15089 PMC 바로가기 [Article Type] Review
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trialSARS-COV-2 감염 (COVID-RED)의 원격 조기 발견을위한 일일 증상 일기 외에 웨어러블 장치의 효과를 조사하기위한 전향 적, 무작위, 단일 맹장, 크로스 오버 시험 : 연구의 구조적 요약.무작위 제어 시험을위한 프로토콜Update Published on 2021-10-112022-09-01 Journal: Trials [Category] MERS, SARS, 임상, 진단, 치료기술, 치료제, [키워드] 1:1 addition adhere Algorithm Algorithms all subject all subjects among others analysed antibody Antibody testing antibody tests Antigen antigen tests approach asked assigned Asymptomatic asymptomatic individual asymptomatic infection average baseline blinded Blinding can not capillary blood Chain Reaction changes in Characteristics cholinergic urticaria Cohort collected Complete conditions conducted consent form contribute control condition COVID-19 COVID-19 infection COVID-19 vaccination current Daily defined demographics described detect detection determine develop deviation diary dissemination Early detection element eligibility criteria eligible End enrolled enrolment evaluate exclusion exploratory feedback Follow-up followed by gold gold standard Health health resource heart rate incidence rates Inclusion inclusion criteria individual individuals infected individual infected individuals infected with SARS-CoV-2 Infection information Informed consent informed consent form initial involved Laboratory laboratory-confirmed SARS-CoV-2 infection machine learning management maximum media medical history Mobile application must nasal swab National natural infection Negative predictive value Netherland Netherlands notification NPV number objective occur outcome pacemaker parameter participant PCR PCR test PCR tests physiological physiological parameters polymerase chain polymerase chain reaction populations portal positive Positive predictive value PPV pre-symptomatic Predictive value primary analysis profession proportion Prospective protocol provided public health Pulse rate questionnaire randomization randomization sequence Randomized Randomized controlled trial Randomly receive recommendation recruited recruitment reduce remote reported resident resource responsible resulting risk RIVM Sample size SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 test SARS-CoV-2 virus sensitivity sequence sequence 1 Sequence 2 sequences serology serology test serology tests significantly skin temperature Smartphone social media specificity staff stratified stratified block randomization study participation Study protocol subject suffering supplementary material Symptom Symptom diary Symptoms target temperature test result tested the SARS-CoV-2 thought Transmission transmissions Trial Trial registration undergo urticaria used to evaluate vaccinated against COVID-19 vaccination Vaccine Variability wearable device website Well-being [DOI] 10.1186/s13063-021-05643-5 PMC 바로가기 [Article Type] Update